The world is currently experiencing a huge challenge which has affected all the industries and markets. Few markets have experienced a high growth in their demand while others have faced a downfall. The extent of growth or drop in the market statistics of different industries by COVID 19 plays an important role in how the future of businesses will shape up in the near future. We at Value Market Research provide you with an impact analysis of COVID 19 on this market with its latest update in the purchased version of the report.
Global In Situ Hybridization Market Report By Technology (Fluorescent In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)), By Probe (DNA, RNA), By Product (Instruments, Kits & Probes, Software, Services), By Application (Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Others), By End-use (Research & Diagnostic Laboratories, CROs, Academic Institutes, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028
ID:VMR11220579
March 2023
Report Formats: Electronic (PDF), MS EXCEL
The global demand for In Situ Hybridization Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
In Situ Hybridization or ISH is a technique used in molecular biology and genetics to detect and localize specific DNA or RNA sequences in cells or tissues. It involves using labelled probes, which are complementary to the target sequence of interest, to bind and hybridize with the nucleic acids in the sample being studied. ISH can be used to identify the presence or absence of specific genetic sequences in cells or tissues, as well as to determine the location of those sequences within the cell or tissue. This technique is widely used in research to study gene expression, chromosomal abnormalities, and viral infections.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in situ hybridization. The growth and trends of in situ hybridization industry provide a holistic approach to this study.
By Technology
By Probe
By Product
By Application
By End-Use
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in situ hybridization market include Thermo Fisher Scientific Inc., Abbott (Abbott Molecular), PerkinElmer Inc., BioView, Agilent Technologies Inc., Merck KGaA, Bio-Rad Laboratories Inc., Oxford Gene Technology IP Limited, Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories Inc., Advanced Cell Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In Situ Hybridization or ISH is a technique used in molecular biology and genetics to detect and localize specific DNA or RNA sequences in cells or tissues. It involves using labelled probes, which are complementary to the target sequence of interest, to bind and hybridize with the nucleic acids in the sample being studied. ISH can be used to identify the presence or absence of specific genetic sequences in cells or tissues, as well as to determine the location of those sequences within the cell or tissue. This technique is widely used in research to study gene expression, chromosomal abnormalities, and viral infections.
Market Dynamics
The development of personalized medicine is dependent on the ability to accurately identify and diagnose genetic mutations and alterations. ISH is a critical tool for this process, enabling researchers and clinicians to detect specific nucleic acid sequences in cells or tissues, which can inform treatment decisions and improve patient outcomes. The field of genomics is rapidly expanding, driven by advances in sequencing technologies and the growing availability of genetic data. ISH is a key tool for studying gene expression and the location of specific genes within the genome, making it an essential technique for genomics research. The prevalence of diseases, such as cancer and neurological disorders, is increasing globally. ISH is a critical tool for diagnosing and treating chronic diseases, enabling clinicians to accurately identify genetic mutations and alterations that contribute to disease development and progression. The development of new probes and detection methods for ISH is driving innovation in the field, enabling researchers and clinicians to detect smaller quantities of nucleic acids with higher accuracy and sensitivity.The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in situ hybridization. The growth and trends of in situ hybridization industry provide a holistic approach to this study.
Market Segmentation
This section of the in situ hybridization market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.By Technology
- Fluorescent In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
By Probe
- DNA
- RNA
By Product
- Instruments
- Kits & Probes
- Software
- Services
By Application
- Cancer
- Cytogenetics
- Developmental Biology
- Infectious Diseases
- Others
By End-Use
- Research & Diagnostic Laboratories
- CROs
- Academic Institutes
- Others
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the In Situ Hybridization market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.Global In Situ Hybridization Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in situ hybridization market include Thermo Fisher Scientific Inc., Abbott (Abbott Molecular), PerkinElmer Inc., BioView, Agilent Technologies Inc., Merck KGaA, Bio-Rad Laboratories Inc., Oxford Gene Technology IP Limited, Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories Inc., Advanced Cell Diagnostics Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . IN SITU HYBRIDIZATION – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Technology
3.7.2 Market Attractiveness Analysis By Probe
3.7.3 Market Attractiveness Analysis By Product
3.7.4 Market Attractiveness Analysis By Application
3.7.5 Market Attractiveness Analysis By End-use
3.7.6 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5. IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY TECHNOLOGY
6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Fluorescent In Situ Hybridization (FISH) Historic and Forecast Sales by Regions
6.5 Chromogenic In Situ Hybridization (CISH) Historic and Forecast Sales by Regions
7 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY PROBE
7.1 Overview by Probe
7.2 Historical and Forecast Data
7.3 Analysis by Probe
7.4 DNA Historic and Forecast Sales by Regions
7.5 RNA Historic and Forecast Sales by Regions
8 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY PRODUCT
8.1 Overview by Product
8.2 Historical and Forecast Data
8.3 Analysis by Product
8.4 Instruments Historic and Forecast Sales by Regions
8.5 Kits & Probes Historic and Forecast Sales by Regions
8.6 Software Historic and Forecast Sales by Regions
8.7 Services Historic and Forecast Sales by Regions
9 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY APPLICATION
9.1 Overview by Application
9.2 Historical and Forecast Data
9.3 Analysis by Application
9.4 Cancer Historic and Forecast Sales by Regions
9.5 Cytogenetics Historic and Forecast Sales by Regions
9.6 Developmental Biology Historic and Forecast Sales by Regions
9.7 Infectious Diseases Historic and Forecast Sales by Regions
9.8 Others Historic and Forecast Sales by Regions
10 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY END-USE
10.1 Overview by End-use
10.2 Historical and Forecast Data
10.3 Analysis by End-use
10.4 Research & Diagnostic Laboratories Historic and Forecast Sales by Regions
10.5 CROs Historic and Forecast Sales by Regions
10.6 Academic Institutes Historic and Forecast Sales by Regions
10.7 Others Historic and Forecast Sales by Regions
11 . GLOBAL IN SITU HYBRIDIZATION MARKET ANALYSIS BY GEOGRAPHY
11.1. Top Company Share Analysis
11.2. Introduction
11.3. North America Sales Analysis
11.3.1. Overview, Historic and Forecast Sales Analysis
11.3.2. North America By Segment Sales Analysis
11.3.3. North America By Country Sales Analysis
11.3.4. United State Sales Analysis
11.3.5. Canada Sales Analysis
11.3.6. Mexico Sales Analysis
11.4. Europe Sales Analysis
11.4.1. Overview, Historic and Forecast Sales Analysis
11.4.2. Europe by Segment Sales Analysis
11.4.3. Europe by Country Sales Analysis
11.4.4. United Kingdom Sales Analysis
11.4.5. France Sales Analysis
11.4.6. Germany Sales Analysis
11.4.7. Italy Sales Analysis
11.4.8. Russia Sales Analysis
11.4.9. Rest Of Europe Sales Analysis
11.5. Asia Pacific Sales Analysis
11.5.1. Overview, Historic and Forecast Sales Analysis
11.5.2. Asia Pacific by Segment Sales Analysis
11.5.3. Asia Pacific by Country Sales Analysis
11.5.4. China Sales Analysis
11.5.5. India Sales Analysis
11.5.6. Japan Sales Analysis
11.5.7. South Korea Sales Analysis
11.5.8. Australia Sales Analysis
11.5.9. Rest Of Asia Pacific Sales Analysis
11.6. Latin America Sales Analysis
11.6.1. Overview, Historic and Forecast Sales Analysis
11.6.2. Latin America by Segment Sales Analysis
11.6.3. Latin America by Country Sales Analysis
11.6.4. Brazil Sales Analysis
11.6.5. Argentina Sales Analysis
11.6.6. Peru Sales Analysis
11.6.7. Chile Sales Analysis
11.6.8. Rest of Latin America Sales Analysis
11.7. Middle East & Africa Sales Analysis
11.7.1. Overview, Historic and Forecast Sales Analysis
11.7.2. Middle East & Africa by Segment Sales Analysis
11.7.3. Middle East & Africa by Country Sales Analysis
11.7.4. Saudi Arabia Sales Analysis
11.7.5. UAE Sales Analysis
11.7.6. Israel Sales Analysis
11.7.7. South Africa Sales Analysis
11.7.8. Rest Of Middle East And Africa Sales Analysis
12 . COMPETITIVE LANDSCAPE OF THE IN SITU HYBRIDIZATION COMPANIES
12.1. In Situ Hybridization Market Competition
12.2. Partnership/Collaboration/Agreement
12.3. Merger And Acquisitions
12.4. New Product Launch
12.5. Other Developments
13 . COMPANY PROFILES OF IN SITU HYBRIDIZATION INDUSTRY
13.1. Company Share Analysis
13.2. Market Concentration Rate
13.3. Thermo Fisher Scientific Inc.
13.3.1. Company Overview
13.3.2. Company Revenue
13.3.3. Products
13.3.4. Recent Developments
13.4. Abbott (Abbott Molecular)
13.4.1. Company Overview
13.4.2. Company Revenue
13.4.3. Products
13.4.4. Recent Developments
13.5. PerkinElmer Inc.
13.5.1. Company Overview
13.5.2. Company Revenue
13.5.3. Products
13.5.4. Recent Developments
13.6. BioView
13.6.1. Company Overview
13.6.2. Company Revenue
13.6.3. Products
13.6.4. Recent Developments
13.7. Agilent Technologies Inc.
13.7.1. Company Overview
13.7.2. Company Revenue
13.7.3. Products
13.7.4. Recent Developments
13.8. Merck KGaA
13.8.1. Company Overview
13.8.2. Company Revenue
13.8.3. Products
13.8.4. Recent Developments
13.9. Bio-Rad Laboratories Inc.
13.9.1. Company Overview
13.9.2. Company Revenue
13.9.3. Products
13.9.4. Recent Developments
13.10. Oxford Gene Technology IP Limited
13.10.1. Company Overview
13.10.2. Company Revenue
13.10.3. Products
13.10.4. Recent Developments
13.11. Leica Biosystems Nussloch GmbH
13.11.1. Company Overview
13.11.2. Company Revenue
13.11.3. Products
13.11.4. Recent Developments
13.12. F. Hoffman-La Roche Limited
13.12.1. Company Overview
13.12.2. Company Revenue
13.12.3. Products
13.12.4. Recent Developments
13.13. NeoGenomics Laboratories Inc.
13.13.1. Company Overview
13.13.2. Company Revenue
13.13.3. Products
13.13.4. Recent Developments
13.14. Advanced Cell Diagnostics Inc.
13.14.1. Company Overview
13.14.2. Company Revenue
13.14.3. Products
13.14.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Technology (USD MN)
- Fluorescent In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
- Chromogenic In Situ Hybridization (CISH) Market Sales by Geography (USD MN)
- Analysis Market by Probe (USD MN)
- DNA Market Sales by Geography (USD MN)
- RNA Market Sales by Geography (USD MN)
- Analysis by Product (USD MN)
- Instruments Market Sales by Geography (USD MN)
- Kits & Probes Market Sales by Geography (USD MN)
- Software Market Sales by Geography (USD MN)
- Services Market Sales by Geography (USD MN)
- Analysis by Application (USD MN)
- Cancer Market Sales by Geography (USD MN)
- Cytogenetics Market Sales by Geography (USD MN)
- Developmental Biology Market Sales by Geography (USD MN)
- Infectious Diseases Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Analysis by End-use (USD MN)
- Research & Diagnostic Laboratories Market Sales by Geography (USD MN)
- CROs Market Sales by Geography (USD MN)
- Academic Institutes Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global In Situ Hybridization Market Sales by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of In Situ Hybridization Report
- Market Research Process
- Market Research Methodology
- Global In Situ Hybridization Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Technology
- Market Attractiveness Analysis by Probe
- Market Attractiveness Analysis by Product
- Market Attractiveness Analysis by Application
- Market Attractiveness Analysis by End-use
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Technology (USD MN)
- Fluorescent In Situ Hybridization (FISH) Market Sales by Geography (USD MN)
- Chromogenic In Situ Hybridization (CISH) Market Sales by Geography (USD MN)
- Global Market Analysis by Probe (USD MN)
- DNA Market Sales by Geography (USD MN)
- RNA Market Sales by Geography (USD MN)
- Global Market Analysis by Product (USD MN)
- Instruments Market Sales by Geography (USD MN)
- Kits & Probes Market Sales by Geography (USD MN)
- Software Market Sales by Geography (USD MN)
- Services Market Sales by Geography (USD MN)
- Global Market Analysis by Application (USD MN)
- Cancer Market Sales by Geography (USD MN)
- Cytogenetics Market Sales by Geography (USD MN)
- Developmental Biology Market Sales by Geography (USD MN)
- Infectious Diseases Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market Analysis by End-use (USD MN)
- Research & Diagnostic Laboratories Market Sales by Geography (USD MN)
- CROs Market Sales by Geography (USD MN)
- Academic Institutes Market Sales by Geography (USD MN)
- Others Market Sales by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Top Company Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Related Categories
Healthcare
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments